My Brilliant Friend executive producer Jennifer Schuur is staying at HBO.

Schuur has renewed her overall deal with the premium cable outlet, which has been her home since 2019. The renewed deal will run through the end of 2024, during which time she’ll continue to develop and produce projects for HBO.

“I deeply value my relationships with the people at HBO who support artists, as well as programming that has made us all think, feel, and want more for decades,” Schuur said in a statement. “I feel very lucky to be at HBO and I cannot wait to see what this next chapter has in store for all of us.”

In addition to My Brilliant Friend, which will wrap after its upcoming fourth season, Schuur was co-showrunner and an executive producer of HBO’s revival of In Treatment in 2021. She is currently adapting Valentine, Elizabeth Wetmore’s best-selling novel about a vicious crime and its aftereffects in 1970s Odessa, Texas. She’s set to executive produce a limited series project based on the book with Wetmore and Salma Hayek and Jose Tamez of Ventanarosa Productions.

Schuur’s other writing and producing credits include Netflix’s Unbelievable — for which she earned Emmy and Writers Guild Award nominations — and NBC’s Hannibal. She is repped by UTA and Tara Kole at Johnson Shapiro.

Also Read More: World News | Entertainment News | Celeb News

Hollywood

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Midterm Mayhem: Washingtonians to Watch in Fall 2022

Primaries are now well underway, and the 2022 midterm elections are a…

Showtime Orders Comedy Pilot From ‘Everything Everywhere All at Once’ Team

Showtime has ordered an autobiographical half-hour comedy pilot titled Mason that will…

‘The Rings of Power’ Showrunners Break Silence on Backlash, Sauron and Season 2

“This is where everything happens,” says showrunner Patrick McKay. “The War Room.”…

Stone Village Television to Adapt Ryan Hampton’s ‘Unsettled’ as Limited Series (Exclusive)

An inside account of the Purdue Pharma bankruptcy is headed to television.…